Glytec logo — Glytec’s leading SaaS platform empowers collaborative diabet...

Glytec

Glytec’s leading SaaS platform empowers collaborative diabetes management and insulin dosing from the hospital to home.

Founded 2006 United States Boston, United States 72 employees Information Technology

General Information

Company Name Glytec
Founded Year 2006
Location United States Boston, United States +1
Employees 72
Industries Information Technology
Social

Get notified when Glytec moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Glytec

Glytec is a leading Information Technology startup, founded in 2006 and headquartered in the United States. Their slogan, "Glytec’s leading SaaS platform empowers collaborative diabetes management and insulin dosing from the hospital to home," encapsulates their mission. With a SaaS platform trusted by 350+ hospitals, Glytec aims to improve patient outcomes, reduce readmissions, and streamline workflows, delivering a remarkable 6-8x ROI. The company's first-ever FDA-cleared cloud-based insulin management software is EMR-integrated, easy to set up, and validated by 106 patents and over 100 publications. Their Glytec Glucommander® solution incorporates clinical decision support, workflow alerts, patient monitoring, at-risk patient identification, and AI-driven analytics. Glytec's mission-driven team is dedicated to helping healthcare leaders, clinicians, and patients promote health equity and improve diabetes outcomes, from hospital to home. Although information about their last funding round and investors is not available at the moment, Glytec's dedication to revolutionizing diabetes management makes them an intriguing prospect for venture capitalists seeking opportunities in the healthcare technology space. Keep an eye on Glytec for future developments by following them on X (@Glytec) or visiting www.Glytec.com.

Taxonomy: diabetes management, insulin dosing, FDA-cleared software, EMR integration, clinical decision support, patient monitoring, AI-driven analytics, health equity, Fortune 1000 organizations, consulting, IBM technologies, Microsoft technologies, Open Source technologies

No funding data available for Glytec yet.

Get notified when Glytec raises funding

Glytec Alternatives & Competitors

Glytec vs
Jade Diabetes
Jade Diabetes Australia

Upgrade Your Diabetes

11-50 employees
Health Care, Information Technology
Glytec vs
Hedia
Hedia Denmark

Our vision is to improve quality of life for people with diabetes and make the best diabetes managem...

Seed
43 employees
AI, Life Sciences
Glytec vs
Dexcom UK
Dexcom UK United Kingdom

The future of Continuous Glucose Monitoring is here.

Post Ipo Debt
22 employees
Health Care

FAQ About Glytec

Glytec’s leading SaaS platform empowers collaborative diabetes management and insulin dosing from the hospital to home.
Glytec was founded in 2006.
Glytec is headquartered in Boston, United States.
Glytec operates in the following industries: Information Technology.
Glytec has approximately 72 employees.
Top alternatives and competitors to Glytec include Jade Diabetes, Hedia, Dexcom UK, DreaMed Diabetes, ARKRAY, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Glytec and Jade Diabetes are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Glytec and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy